• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于个体供者特征使用机器学习预测体外人间质基质细胞扩增。

Predicting in vitro human mesenchymal stromal cell expansion based on individual donor characteristics using machine learning.

机构信息

Biomechanics Research Unit, GIGA In Silico Medicine, University of Liege, CHU - BAT 34, Quartier Hopital, Liege, Belgium; Prometheus, the Division of Skeletal Tissue Engineering, KU Leuven, Onderwijs en Navorsing 1 (+8), Leuven, Belgium.

Prometheus, the Division of Skeletal Tissue Engineering, KU Leuven, Onderwijs en Navorsing 1 (+8), Leuven, Belgium; M3-BIORES, KU Leuven, Leuven, Onderwijs en Navorsing 1 (+8), Leuven, Belgium.

出版信息

Cytotherapy. 2020 Feb;22(2):82-90. doi: 10.1016/j.jcyt.2019.12.006. Epub 2020 Jan 25.

DOI:10.1016/j.jcyt.2019.12.006
PMID:31987754
Abstract

BACKGROUND

Human mesenchymal stromal cells (hMSCs) have become attractive candidates for advanced medical cell-based therapies. An in vitro expansion step is routinely used to reach the required clinical quantities. However, this is influenced by many variables including donor characteristics, such as age and gender, and culture conditions, such as cell seeding density and available culture surface area. Computational modeling in general and machine learning in particular could play a significant role in deciphering the relationship between the individual donor characteristics and their growth dynamics.

METHODS

In this study, hMSCs obtained from 174 male and female donors, between 3 and 64 years of age with passage numbers ranging from 2 to 27, were studied. We applied a Random Forests (RF) technique to model the cell expansion procedure by predicting the population doubling time (PDT) for each passage, taking into account individual donor-related characteristics.

RESULTS

Using the RF model, the mean absolute error between model predictions and experimental results for the PDT in passage 1 to 4 is significantly lower compared with the errors obtained with theoretical estimates or historical data. Moreover, statistical analysis indicate that the PD and PDT in different age categories are significantly different, especially in the youngest group (younger than 10 years of age) compared with the other age groups.

DISCUSSION

In summary, we introduce a predictive computational model describing in vitro cell expansion dynamics based on individual donor characteristics, an approach that could greatly assist toward automation of a cell expansion culture process.

摘要

背景

人类间充质基质细胞(hMSCs)已成为先进的医学细胞治疗的有吸引力的候选者。通常使用体外扩增步骤来达到所需的临床数量。然而,这受到许多变量的影响,包括供体特征,如年龄和性别,以及培养条件,如细胞接种密度和可用的培养表面积。计算建模,特别是机器学习,可以在破译个体供体特征与其生长动力学之间的关系方面发挥重要作用。

方法

在这项研究中,研究了来自 174 名年龄在 3 至 64 岁之间的男性和女性供体的 hMSCs,其传代数从 2 到 27。我们应用随机森林(RF)技术来通过预测每个传代的群体倍增时间(PDT)来对细胞扩增过程进行建模,同时考虑到个体供体相关特征。

结果

使用 RF 模型,与理论估计或历史数据相比,1 至 4 代 PDT 的模型预测与实验结果之间的平均绝对误差明显更低。此外,统计分析表明,不同年龄组的 PD 和 PDT 存在显著差异,尤其是在最年轻的组(10 岁以下)与其他年龄组相比。

讨论

总之,我们引入了一种基于个体供体特征的体外细胞扩增动力学预测计算模型,这种方法可以极大地协助细胞扩增培养过程的自动化。

相似文献

1
Predicting in vitro human mesenchymal stromal cell expansion based on individual donor characteristics using machine learning.基于个体供者特征使用机器学习预测体外人间质基质细胞扩增。
Cytotherapy. 2020 Feb;22(2):82-90. doi: 10.1016/j.jcyt.2019.12.006. Epub 2020 Jan 25.
2
Donor age and long-term culture affect differentiation and proliferation of human bone marrow mesenchymal stem cells.供体年龄和长期培养会影响人骨髓间充质干细胞的分化和增殖。
Ann Hematol. 2012 Aug;91(8):1175-86. doi: 10.1007/s00277-012-1438-x. Epub 2012 Mar 8.
3
Proliferative and osteogenic differentiation capacity of mesenchymal stromal cells: Influence of harvesting site and donor age.间充质基质细胞的增殖和成骨分化能力:取材部位和供体年龄的影响
Injury. 2018 Aug;49(8):1504-1512. doi: 10.1016/j.injury.2018.06.024. Epub 2018 Jun 21.
4
Donor Variability in Growth Kinetics of Healthy hMSCs Using Manual Processing: Considerations for Manufacture of Cell Therapies.使用手动处理时健康 hMSC 生长动力学的供体变异性:细胞治疗制造的考虑因素。
Biotechnol J. 2018 Feb;13(2). doi: 10.1002/biot.201700085. Epub 2018 Jan 25.
5
Quantifying in vitro growth and metabolism kinetics of human mesenchymal stem cells using a mathematical model.使用数学模型量化人间充质干细胞的体外生长和代谢动力学
Tissue Eng Part A. 2009 Sep;15(9):2653-63. doi: 10.1089/ten.TEA.2008.0328.
6
Sub-confluent culture of human mesenchymal stromal cells on biodegradable polycaprolactone microcarriers enhances bone healing of rat calvarial defect.微载体上亚汇合培养的人骨髓间充质干细胞增强了大鼠颅骨缺损的骨愈合。
Cytotherapy. 2019 Jun;21(6):631-642. doi: 10.1016/j.jcyt.2019.03.004. Epub 2019 Apr 8.
7
Translation of a standardized manufacturing protocol for mesenchymal stromal cells: A systematic comparison of validation and manufacturing data.间质基质细胞标准化制造方案的翻译:验证和制造数据的系统比较。
Cytotherapy. 2019 Apr;21(4):468-482. doi: 10.1016/j.jcyt.2019.03.001. Epub 2019 Mar 27.
8
Human bone marrow stromal cell confluence: effects on cell characteristics and methods of assessment.人骨髓基质细胞汇合度:对细胞特性的影响及评估方法
Cytotherapy. 2015 Jul;17(7):897-911. doi: 10.1016/j.jcyt.2015.03.607. Epub 2015 Apr 14.
9
Effect of donor characteristics, technique of harvesting and in vitro processing on culturing of human marrow stroma cells for tissue engineered growth of bone.供体特征、采集技术及体外处理对用于骨组织工程生长的人骨髓基质细胞培养的影响
Clin Oral Implants Res. 2005 Oct;16(5):524-31. doi: 10.1111/j.1600-0501.2005.01142.x.
10
The Impact of Harvesting Systems and Donor Characteristics on Viability of Nucleated Cells in Adipose Tissue: A First Step Towards a Manufacturing Process.采集系统和供体特征对脂肪组织中有核细胞活力的影响:迈向制造工艺的第一步。
J Craniofac Surg. 2019 May/Jun;30(3):716-720. doi: 10.1097/SCS.0000000000005310.

引用本文的文献

1
Living Medicines Engineered to Fight: A Comprehensive Review on CAR T-Cell Therapy.用于战斗的活体药物:嵌合抗原受体T细胞疗法综述
Int J Hematol Oncol Stem Cell Res. 2025 Apr 1;19(2):180-190. doi: 10.18502/ijhoscr.v19i2.18555.
2
Equine Colostrum-Derived Mesenchymal Stromal Cells: A Potential Resource for Veterinary Regenerative Medicine.马初乳来源的间充质基质细胞:兽医再生医学的潜在资源。
Vet Sci. 2025 Jul 19;12(7):681. doi: 10.3390/vetsci12070681.
3
Regression models for the prediction of the influence of magnesium ions on primary endothelial cell (HUVEC) proliferation and migration.
用于预测镁离子对人脐静脉内皮细胞(HUVEC)增殖和迁移影响的回归模型。
Comput Struct Biotechnol J. 2025 Jun 8;27:2711-2718. doi: 10.1016/j.csbj.2025.06.023. eCollection 2025.
4
A Mathematical Model for Determining Probabilistic Design Space in Mesenchymal Stem Cell Passage Culture.一种用于确定间充质干细胞传代培养中概率设计空间的数学模型。
Biotechnol Bioeng. 2025 Apr 25. doi: 10.1002/bit.29001.
5
Broadening the horizon: potential applications of CAR-T cells beyond current indications.拓宽视野:CAR-T 细胞在现有适应证之外的潜在应用。
Front Immunol. 2023 Nov 27;14:1285406. doi: 10.3389/fimmu.2023.1285406. eCollection 2023.
6
Functional enhancement strategies to potentiate the therapeutic properties of mesenchymal stromal cells for respiratory diseases.增强间充质基质细胞治疗呼吸系统疾病治疗特性的功能增强策略。
Front Pharmacol. 2023 Mar 16;14:1067422. doi: 10.3389/fphar.2023.1067422. eCollection 2023.
7
Toward Rapid, Widely Available Autologous CAR-T Cell Therapy - Artificial Intelligence and Automation Enabling the Smart Manufacturing Hospital.迈向快速、广泛可用的自体嵌合抗原受体T细胞疗法——人工智能与自动化助力智能制造医院
Front Med (Lausanne). 2022 Jun 6;9:913287. doi: 10.3389/fmed.2022.913287. eCollection 2022.
8
A Systematically Reduced Mathematical Model for Organoid Expansion.一种用于类器官扩增的系统简化数学模型。
Front Bioeng Biotechnol. 2021 Jun 10;9:670186. doi: 10.3389/fbioe.2021.670186. eCollection 2021.
9
Research Progress on Strategies that can Enhance the Therapeutic Benefits of Mesenchymal Stromal Cells in Respiratory Diseases With a Specific Focus on Acute Respiratory Distress Syndrome and Other Inflammatory Lung Diseases.间充质基质细胞在呼吸系统疾病中增强治疗效果的策略研究进展,特别关注急性呼吸窘迫综合征和其他炎症性肺病
Front Pharmacol. 2021 Apr 19;12:647652. doi: 10.3389/fphar.2021.647652. eCollection 2021.
10
Automation, Monitoring, and Standardization of Cell Product Manufacturing.细胞产品制造的自动化、监测与标准化
Front Bioeng Biotechnol. 2020 Jul 14;8:811. doi: 10.3389/fbioe.2020.00811. eCollection 2020.